We can’t show the full text here under this license. Use the link below to read it at the source.
Ciprofol Alleviates Depressive-Like Behaviors in CUMS Mice Through PPARα-Associated ERK/CREB Signaling Activation
Ciprofol reduces depression-like behaviors in stressed mice by activating PPARα-related ERK/CREB signaling
AI simplified
Abstract
Ciprofol treatment reduced immobility time and increased sucrose preference in mice subjected to chronic unpredictable mild stress.
- Ciprofol alleviated depressive behaviors in mice, indicating potential antidepressant effects.
- The treatment suppressed microglial activation in the prefrontal cortex and downregulated pro-inflammatory cytokines.
- Ciprofol preserved synaptic integrity by inhibiting microglia-mediated synaptic phagocytosis.
- Transcriptome analysis suggests that the antidepressant effect of ciprofol may be linked to PPARα activation.
- Activation of PPARα could trigger the ERK/CREB signaling pathway, contributing to the observed effects.
AI simplified
Key numbers
p=0.0079
Increase in Sucrose Preference
Significant increase in sucrose preference after a single dose of ciprofol.
102.2 ± 27.07 s
Decrease in Immobility Time
Immobility time in + Ciprofol group compared to 132.7 ± 28.37 s in group (p=0.0214).
144.6 ± 11.97 cells/mm²
Reduction in Microglial Activation
Microglial density in + Ciprofol group compared to 193.2 ± 23.71 cells/mm² in group (p=0.0062).